Related Experiment Video
Updated: Jul 5, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Biapenem American Cyanamid Co
1R W Johnson Pharmaceutical Research Institute, Welsh and McKean Roads, R-439, Spring House, PA 19477-0776, USA. SDax@prius.jnj.com
Abstract:
Biapenem is an injectable carbapenem antibiotic with activity against a broad spectrum of bacteria [155679]. It has been submitted for marketing approval in Japan by Lederle Japan, a joint venture between Cyanamid and Takeda. Biapenem is in phase III trials in Germany, South Africa, Spain, Australia and New Zealand for skin infections, and phase I trials in the UK and the US.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Production of Antibiotics
Physical Properties of Amines
Acute Pyelonephritis II: Diagnostic Studies and Management